Infirst Healthcare’s Flarin is the winner of the CHi Award for Innovation of the Year, with one judge describing the medicine for flaring joint pain and inflammation as a “potential game changer”.
“Known drugs – made better” is how Infirst Healthcare sums up its approach to OTC innovation. Speaking to OTCToolbox in 2014, Chief Executive Officer Manfred Scheske said the OTC industry needed to rethink its approach to innovation, buy into the concept of constantly improving drugs and treatments, and be ready to conduct clinical trials to generate evidence. “Only then will the industry be able to fully unlock its fantastic potential,” he commented.
